Jun 23, 2014 by Dave Williamson and Michael DouglassCost Controls vs. Curing Citizens: Fallout from the U.K.What Are Government's Willing to Pay to Cure Hepatitis C?
Jun 23, 2014 by Dave Williamson and Michael DouglassShots Fired in the Next Tax Fleeing BattleAbbVie has made a move on Shire, but will a bidding war emerge for the Irish drugmaker?
Jun 23, 2014 by Dave Williamson and Joel SouthBetter Stock Today Challenge: Gilead vs. Vanguard Natural ResourcesIn the spirit of World Cup competition, we’re holding our own tournament in search of the Better Stock Today.
Jun 22, 2014 by Dave Williamson and Michael DouglassBetter Buy: Merck vs Pfizer Stockits a big pharma showdown in this game of would you rather
Jun 22, 2014 by Dave Williamson and Michael DouglassFDA Drops the Hammer on TwitterNew FDA regulations makes pharma companies describe benefits and risks of drugs in 140 characters
Jun 22, 2014 by Dave Williamson and Michael Douglass#1 Hostile Healthcare Rule: Eat or Be EatenAllergan may have to acquire Shire to avoid Ackman and Valeant's hostile pursuit
Jun 20, 2014 by Dave Williamson and Joel SouthBetter Stock Today Challenge: Isis Pharmaceuticals vs. Energy Transfer PartnersIn the spirit of World Cup competition, we’re holding our own tournament in search of the Better Stock Today.
Jun 20, 2014 by Dave Williamson and Joel SouthBetter Stock Today Challenge: Gilead vs. DistributionNowIn the spirit of World Cup competition, we’re holding our own tournament in search of the Better Stock Today.
Jun 19, 2014 by Dave Williamson and Mark ReethBetter Stock Today Challenge: Johnson & Johnson vs. SodaStreamIn the spirit of World Cup competition, we’re holding our own tournament in search of the Better Stock Today.
Jun 18, 2014 by Dave Williamson and Michael DouglassIs This the Next Blockbuster MS Treatment?Biogen and AbbVie team up for phase 3 success
Jun 18, 2014 by Dave Williamson and Jamal Carnette, CFABetter Stock Today Challenge: Celgene vs. FacebookIn the spirit of World Cup competition, we’re holding our own tournament in search of the Better Stock Today.
Jun 16, 2014 by Dave Williamson and Joel SouthBetter Stock Today Challenge: Johnson & Johnson vs. DistributionNowIn the spirit of World Cup competition, we’re holding our own tournament in search of the Better Stock Today.
Jun 16, 2014 by Dave Williamson and Joel SouthBetter Stock Today Challenge: Isis Pharmaceuticals vs. LINN EnergyIn the spirit of World Cup competition, we’re holding our own tournament in search of the Better Stock Today.
Jun 16, 2014 by Dave WilliamsonBetter Stock Today Challenge: Gilead vs. SeadrillIn the spirit of World Cup competition, we’re holding our own tournament in search of the Better Stock Today.
Jun 15, 2014 by Dave Williamson and nathan HamiltonBetter Stock Today: Gilead vs. Amazon.comIn the spirit of World Cup competition, we’re holding our own tournament in search of the Better Stock Today.
Jun 9, 2014 by Dave Williamson and Michael DouglassWill the Next Big Healthcare Takeover Spark a Bidding War?Will a bidding war break out over Smith and Nephew?
Jun 8, 2014 by Dave WilliamsonFast Tracked: 1 More Reason to Invest in this "Marijuana Stock" MultibaggerGW Pharmaceuticals received a fast track designation for epidiolex gives its 700% gains legs
May 31, 2014 by Dave Williamson and Michael DouglassEcigs Help Smokers Quit: Key Investor TakeawaysLorillard Inc. and Altria Group Inc. are two companies looking to benefit from ecigs' popularity among those who are trying to quit traditional smoking.
May 31, 2014 by Dave Williamson and Michael DouglassMarijuana Stocks and Why Investors Can't Profit From Colorado's Pot BoomAre there any stocks to play the Colorado Pot Boom?
May 31, 2014 by Dave Williamson and Michael DouglassSurprising MS Drug Approval: Time to Buy?The EU has issued a preliminary approval for Translarn, the Duchenne muscular dystrophy drug developed by PTC Therapeutics.
